Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,677,542
-
Share change
-
-212,663
-
Total reported value
-
$14,511,000
-
Price per share
-
$5.42
-
Number of holders
-
16
-
Value change
-
-$1,158,812
-
Number of buys
-
1
-
Number of sells
-
12
Institutional Holders of HTG MOLECULAR DIAGNOSTICS IN - COM NEW (HTGM) as of Q4 2021
As of 31 Dec 2021,
HTG MOLECULAR DIAGNOSTICS IN - COM NEW (HTGM) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,677,542 shares.
The largest 10 holders included
AIGH Capital Management LLC, Cowen Prime Advisors LLC, Samjo Capital LLC, Nantahala Capital Management, LLC, VANGUARD GROUP INC, Worth Venture Partners, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., and STATE STREET CORP.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.